Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyrotoxic periodic paralysis.

Shih-Hua Lin1

  • 1Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. shihhualin@yahoo.com

Mayo Clinic Proceedings
|January 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Case | Heart failure, acute kidney injury, and a dilated aortic root in a young adult.

Kidney international·2026
Same author

Heart Failure Phenotypes and the Prognostic Utility of NT-proBNP in Patients With Chronic Kidney Disease: A Propensity-Score Matched Cohort Study.

Mayo Clinic proceedings·2026
Same author

Very Early Biologic Therapy within Six Months of Crohn's Disease Diagnosis Improves One-Year Steroid-Free Clinical Remission: A Retrospective Cohort Study.

Digestion·2026
Same author

AI-enabled electrocardiogram alert for potassium imbalance treatment: a pragmatic randomized controlled trial.

Nature communications·2026
Same author

Neonatal hypocalcemia caused by maternal hypercalcemia: clinical characteristics, etiology, treatment, and outcome.

Pediatric research·2025
Same author

Artificial intelligence-enabled electrocardiography from scientific research to clinical application.

EMBO molecular medicine·2025
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
Same journal

In Reply: Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study.

Mayo Clinic proceedings·2026
See all related articles

Thyrotoxic periodic paralysis (TPP) is a condition linked to hyperthyroidism causing hypokalemia and muscle weakness. Early diagnosis and treatment are crucial to prevent severe complications and manage attacks effectively.

Area of Science:

  • Endocrinology
  • Neurology
  • Internal Medicine

Background:

  • Thyrotoxic periodic paralysis (TPP) is an increasingly recognized condition in Western countries.
  • It is characterized by hyperthyroidism-associated hypokalemia and muscle weakness due to potassium shifting into cells.
  • Failure to recognize TPP can lead to improper patient management, especially since many patients lack obvious hyperthyroid symptoms.

Purpose of the Study:

  • To highlight key diagnostic clues for TPP.
  • To outline effective management strategies for TPP.
  • To emphasize the importance of early diagnosis and treatment to prevent complications.

Main Methods:

  • Review of clinical presentation and diagnostic findings in TPP patients.
  • Analysis of electrocardiography (ECG) and electromyography (EMG) characteristics.

Related Experiment Videos

  • Evaluation of acid-base and electrolyte profiles, including urinary potassium, phosphate, and calcium excretion.
  • Main Results:

    • Diagnostic clues include adult males without family history, hypertension, tachycardia, specific ECG findings (high QRS voltage, first-degree AV block), and EMG abnormalities.
    • Characteristic electrolyte findings include hypokalemia with low urinary potassium, hypophosphatemia with hypophosphaturia, and hypercalciuria.
    • Immediate potassium chloride supplementation aids recovery but carries a risk of rebound hyperkalemia; nonselective beta-blockers are an alternative.

    Conclusions:

    • Early recognition of TPP is vital, especially in patients presenting with muscle weakness without overt hyperthyroid symptoms.
    • Prompt treatment with potassium supplementation or beta-blockers, alongside definitive hyperthyroid management, can prevent serious complications.
    • Controlling hyperthyroidism is key to completely preventing future TPP attacks.